ARIAD Pharmaceuticals (ARIA) Prices 21.5 Million Share Public Offering at $10.42/Share

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the pricing of an underwritten public offering of 21,500,000 shares of its common stock, at a price to the public of $10.42 per share. The offering is expected to close on or about December 20, 2011, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 3,225,000 additional shares of common stock to cover over-allotments, if any.

J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the offering. BMO Capital Markets Corp., Leerink Swann LLC, Oppenheimer & Co. Inc., and Rodman & Renshaw, LLC are acting as co-managers for the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Singularity Future Technology closes $5M registered direct offering
• Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders